Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer

類似資料

• Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer
  著者:: Dahan Laetitia, 等
  出版事項: (2011-11-01)
• Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab–irinotecan
  著者:: Etienne-Grimaldi, Marie-Christine, 等
  出版事項: (2012)
• Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo
  著者:: Nouguerède, Emilie, 等
  出版事項: (2013)
• Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines
  著者:: Dahan, Laetitia, 等
  出版事項: (2009)
• Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
  著者:: Sibertin-Blanc, Camille, 等
  出版事項: (2013)